AIM
MDXG icon

Acrospire Investment Management’s MiMedx Group MDXG Stock Holding History

Acrospire Investment Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,769
Closed -$101K – 846
2017
Q2 		$101K Buy
6,769
+5,900
+679% +$78.7K 0.09% 243
2017
Q1 		$8K Buy
+869
New +$7.34K 0.01% 1910
2016
Q3 		– Sell
-5,621
Closed -$45K – 2080
2016
Q2 		$45K Sell
5,621
-28,025
-83% -$218K 0.03% 1137
2016
Q1 		$294K Buy
+33,646
New +$280K 0.2% 41

Other funds holding MDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acrospire Investment Management's MDXG Position: Q3 2017 in Review

Acrospire Investment Management sold out of MiMedx Group (MDXG) in Q3 2017, closing a stake of 6,769 shares — an estimated $101K sold.

Acrospire Investment Management first reported a position in MDXG in Q1 2016 and held it in 4 quarters. The position peaked at $294K in Q1 2016. 232 funds tracked by Wall St. Rank hold MDXG as of Q3 2017.

  • Acrospire Investment Management reported no remaining MiMedx Group position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 6,769 MiMedx Group shares in Q3 2017, an estimated $101K.
  • Acrospire Investment Management first reported a position in MiMedx Group in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's MiMedx Group position peaked at $294K in Q1 2016.
  • 232 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.